'Masked' cancer drug stealthily trains immune system to kill tumors while sparing healthy tissues, reducing treatment side effects
- Written by Aslan Mansurov, Postdoctoral Researcher in Molecular Engineering, University of Chicago Pritzker School of Molecular Engineering
Dendritic cells (green) produce cytokines like IL-12, which can train T cells (pink) to attack tumors.Victor Segura Ibarra and Rita Serda/National Cancer Institute via Flickr, CC BY-NCMany cancer treatments are notoriously savage on the body. Drugs often attack both healthy cells and tumor cells, causing a plethora of side effects. Immunotherapies...









